Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

Aima Sense

Swedish Women’s Health Startup Aima Sense Claims Million-Euro Losses from Social Media Censorship

September 21, 2026 by Lars Eriksson

Aima Sense, a Swedish women’s health startup, reports losing millions due to social‑media censorship and has escalated the issue to the government. The company is now looking for investors and a strategic partner to fund its growth and become a global brand.

Categories Funding Tags Aima Sense, Healthtech, Seed, Sweden Leave a comment
Browse by Country

Latest

Fourthline and Veridas merge to create European digital identity powerhouse backed by €65 million funding roundNov 6, 2026
German Robotics Startup Neura Robotics Secures Record $1.4 Billion Funding RoundNov 6, 2026
Swedish AI Legal Tech Startup Harvey in Advanced IPO DiscussionsNov 6, 2026
Swedish AI Startup Modal Reaches $14.5 Billion Valuation in Major Milestone for European TechNov 6, 2026
Finnish Deeptech Startup Vensum Power Secures €9 Million Series A to Scale Power Conversion TechnologyNov 6, 2026

EU Markets

Europe's Financial Pulse: AI Bets, Rate Signals, and What Founders Need to Know This WeekNov 6, 2026
European Markets Flash Caution Signals: What This Week's Financial Turbulence Means for Startup FoundersOct 30, 2026
European Startups, Brace Yourselves: Rate Pressures, AI Disruption, and a €550M Legal Tech Unicorn Define This Week's Financial LandscapeOct 23, 2026
French Debt Fears, AI Tailwinds, and a New Unicorn: What Europe's Financial Markets Mean for Your Startup This WeekOct 16, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.